Ann: Board Change, page-26

The scoping study's values must now be considered to be superseded:
845,000 recoverable ozs is too low based on the results received after the scoping study.
The gp of $2750 per oz is too low with the price now over $3000.
The running expenses are very solid with capital raised, apparently, with no further share dilution.
The NPV is discounted a further 8% for a 7 year net pre tax amount of $442 million. I'm confident that amount will double: ~ $800 million.
That's a dividend approaching 20c.
Feysville, the base metals and AG not included.

So, if not $2, then what?